Literature DB >> 18073344

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.

Martin M Fabani1, Michael J Gait.   

Abstract

MicroRNAs are small noncoding RNAs that regulate many cellular processes in a post-transcriptional mode. MicroRNA knockdown by antisense oligonucleotides is a useful strategy to explore microRNA functionality and as potential therapeutics. MicroRNA-122 (miR-122) is a liver-specific microRNA, the main function of which has been linked with lipid metabolism and liver homeostasis. Here, we show that lipofection of an antisense oligonucleotide based on a Locked Nucleic Acids (LNA)/2'-O-methyl mixmer or electroporation of a Peptide Nucleic Acid (PNA) oligomer is effective at blocking miR-122 activity in human and rat liver cells. These oligonucleotide analogs, evaluated for the first time in microRNA inhibition, are more effective than standard 2'-O-methyl oligonucleotides in binding and inhibiting microRNA action. We also show that microRNA inhibition can be achieved without the need for transfection or electroporation of the human or rat cell lines, by conjugation of an antisense PNA to the cell-penetrating peptide R6-Penetratin, or merely by linkage to just four Lys residues, highlighting the potential of PNA for future therapeutic applications as well as for studying microRNA function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073344      PMCID: PMC2212241          DOI: 10.1261/rna.844108

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  55 in total

1.  Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing.

Authors:  Gunter Meister; Markus Landthaler; Yair Dorsett; Thomas Tuschl
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

2.  Disulfide conjugation of peptides to oligonucleotides and their analogs.

Authors:  John J Turner; Donna Williams; David Owen; Michael J Gait
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2006-04

3.  Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.

Authors:  A Arzumanov; A P Walsh; V K Rajwanshi; R Kumar; J Wengel; M J Gait
Journal:  Biochemistry       Date:  2001-12-04       Impact factor: 3.162

Review 4.  Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone.

Authors:  P E Nielsen; M Egholm; O Buchardt
Journal:  Bioconjug Chem       Date:  1994 Jan-Feb       Impact factor: 4.774

5.  Systemically delivered antisense oligomers upregulate gene expression in mouse tissues.

Authors:  Peter Sazani; Federica Gemignani; Shin-Hong Kang; Martin A Maier; Muthiah Manoharan; Magnus Persmark; Donna Bortner; Ryszard Kole
Journal:  Nat Biotechnol       Date:  2002-11-11       Impact factor: 54.908

6.  The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism.

Authors:  Peizhang Xu; Stephanie Y Vernooy; Ming Guo; Bruce A Hay
Journal:  Curr Biol       Date:  2003-04-29       Impact factor: 10.834

7.  Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder.

Authors:  Thipparat Suwanmanee; Halina Sierakowska; Suthat Fucharoen; Ryszard Kole
Journal:  Mol Ther       Date:  2002-12       Impact factor: 11.454

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.

Authors:  Andrey Arzumanov; Dmitry A Stetsenko; Andrey D Malakhov; Stefanie Reichelt; Mads D Sørensen; B Ravindra Babu; Jesper Wengel; Michael J Gait
Journal:  Oligonucleotides       Date:  2003

10.  T-box gene tbx5 is essential for formation of the pectoral limb bud.

Authors:  Dae-gwon Ahn; Matthew J Kourakis; Laurel A Rohde; Lee M Silver; Robert K Ho
Journal:  Nature       Date:  2002-06-13       Impact factor: 49.962

View more
  111 in total

Review 1.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 2.  Insights on chiral, backbone modified peptide nucleic acids: Properties and biological activity.

Authors:  Maria Moccia; Mauro F A Adamo; Michele Saviano
Journal:  Artif DNA PNA XNA       Date:  2016-01-11

Review 3.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

4.  The silent (R)evolution of polymeric nucleic acid therapeutics.

Authors:  Ernst Wagner
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

Review 5.  The non-coding road towards cardiac regeneration.

Authors:  James E Hudson; Enzo R Porrello
Journal:  J Cardiovasc Transl Res       Date:  2013-12       Impact factor: 4.132

6.  Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells.

Authors:  Michael D Horwich; Phillip D Zamore
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 7.  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Evi Lianidou; Zissimos Mourelatos
Journal:  RNA       Date:  2009-06-26       Impact factor: 4.942

8.  Non-inhibited miRNAs shape the cellular response to anti-miR.

Authors:  John R Androsavich; B Nelson Chau
Journal:  Nucleic Acids Res       Date:  2014-05-07       Impact factor: 16.971

Review 9.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

Review 10.  Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics.

Authors:  Marc S Weinberg; Matthew J A Wood
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.